Tilray Inc (NASDAQ:TLRY – Get Free Report) shares fell 0.3% during trading on Thursday . The stock traded as low as $1.66 and last traded at $1.68. 4,322,725 shares traded hands during trading, a decline of 83% from the average session volume of 25,068,988 shares. The stock had previously closed at $1.68.
Tilray Trading Down 0.3 %
The stock has a 50-day simple moving average of $1.79 and a 200 day simple moving average of $1.88. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The company has a market cap of $1.31 billion, a price-to-earnings ratio of -3.85 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last issued its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.15) EPS. As a group, equities research analysts predict that Tilray Inc will post -0.16 EPS for the current fiscal year.
Hedge Funds Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
- Five stocks we like better than Tilray
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Financial Stocks Poised to Outperform in 2024
- Energy and Oil Stocks Explained
- Has Costco Stock Run its Course for Now?
- What Are Dividends? Buy the Best Dividend Stocks
- October’s 4 Best Penny Stocks: High-Risk, High-Reward Picks
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.